Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Liabilities and Shareholders Equity (2016 - 2025)

Sonoma Pharmaceuticals has reported Liabilities and Shareholders Equity over the past 15 years, most recently at $13.6 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity changed 0.33% year-over-year to $13.6 million; the TTM value through Dec 2025 reached $55.8 million, changed 0.0%, while the annual FY2025 figure was $13.7 million, 7.1% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $13.6 million at Sonoma Pharmaceuticals, down from $13.9 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $19.8 million in Q3 2021 and troughed at $13.6 million in Q4 2025.
  • A 5-year average of $15.3 million and a median of $14.6 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • On a YoY basis, Liabilities and Shareholders Equity climbed as much as 25.74% in 2022 and fell as far as 28.01% in 2022.
  • Year by year, Liabilities and Shareholders Equity stood at $19.3 million in 2021, then fell by 28.01% to $13.9 million in 2022, then rose by 4.95% to $14.6 million in 2023, then decreased by 6.5% to $13.7 million in 2024, then dropped by 0.33% to $13.6 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for SNOA at $13.6 million in Q4 2025, $13.9 million in Q3 2025, and $14.6 million in Q2 2025.